Biopsy-proven immune reconstitution syndrome in a patient with AIDS and cerebral toxoplasmosis.
Pfeffer
Gerald
G
Division of Neurology, University of British Columbia, Room 8219, GLDHCC, 2775 Laurel St, Vancouver, BC V5Z 1M9, Canada. gpfeffer@interchange.ubc.ca
Prout
Alister
A
Hooge
John
J
Maguire
John
J
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy / Q000276:immunology*; D000328:Adult; D000818:Animals; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D001706:Biopsy; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology; D002981:Clindamycin / Q000627:therapeutic use; D005625:Frontal Lobe / Q000469:parasitology / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000175:diagnosis* / Q000276:immunology* / Q000503:physiopathology; D007074:Immunoglobulin G / Q000032:analysis / Q000097:blood; D008213:Lymphocyte Activation / Q000276:immunology; D008279:Magnetic Resonance Imaging; D008297:Male; D010672:Phenytoin / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D012640:Seizures / Q000188:drug therapy / Q000469:parasitology / Q000503:physiopathology; D014122:Toxoplasma / Q000166:cytology / Q000276:immunology; D016781:Toxoplasmosis, Cerebral / Q000276:immunology* / Q000503:physiopathology; D016896:Treatment Outcome
D007074:Immunoglobulin G; D002981:Clindamycin; D010672:Phenytoin; D011739:Pyrimethamine